|Bid||1.22 x 1000|
|Ask||1.49 x 1000|
|Day's Range||1.27 - 1.36|
|52 Week Range||0.67 - 5.10|
|PE Ratio (TTM)||0.92|
|Earnings Date||Mar 13, 2017 - Mar 17, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||0.54|
VALENCIA, Calif., July 17, 2017-- MannKind Corporation today announced that Steven Binder has joined the company as its Chief Financial Officer with full responsibilities for leading MannKind’ s finance, ...
NEW YORK, NY / ACCESSWIRE / July 14, 2017 / AstraZeneca;s shares took a tumble yesterday as traders learned the compan'’s CEO has accepted a position at TEVA, an Israeli-based genetics company. Many investors ...
MannKind (MNKD) needs investors to pay close attention to the stock based on moves in the options market lately.